| The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD P Angulo, JM Hui, G Marchesini, E Bugianesi, J George, GC Farrell, ... Hepatology 45 (4), 846-854, 2007 | 4058 | 2007 |
| Serum markers detect the presence of liver fibrosis: a cohort study WMC Rosenberg, M Voelker, R Thiel, M Becka, A Burt, D Schuppan, ... Gastroenterology 127 (6), 1704-1713, 2004 | 1530 | 2004 |
| Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management S McPherson, T Hardy, E Henderson, AD Burt, CP Day, QM Anstee Journal of hepatology 62 (5), 1148-1155, 2015 | 1384 | 2015 |
| The natural history of nonalcoholic fatty liver: a follow‐up study MR Teli, OFW James, AD Burt, MK Bennett, CP Day Hepatology 22 (6), 1714-1719, 1995 | 1297 | 1995 |
| Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease S McPherson, SF Stewart, E Henderson, AD Burt, CP Day Gut 59 (9), 1265-1269, 2010 | 1148 | 2010 |
| Cellular senescence drives age-dependent hepatic steatosis M Ogrodnik, S Miwa, T Tchkonia, D Tiniakos, CL Wilson, A Lahat, CP Day, ... Nature communications 8 (1), 15691, 2017 | 1082 | 2017 |
| Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis S McPherson, T Hardy, JF Dufour, S Petta, M Romero-Gomez, M Allison, ... Official journal of the American College of Gastroenterology| ACG 112 (5 …, 2017 | 1007 | 2017 |
| Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers IN Guha, J Parkes, P Roderick, D Chattopadhyay, R Cross, S Harris, ... Hepatology 47 (2), 455-460, 2008 | 999 | 2008 |
| TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease YL Liu, HL Reeves, AD Burt, D Tiniakos, S McPherson, JBS Leathart, ... Nature communications 5 (1), 4309, 2014 | 802 | 2014 |
| EASL clinical practical guidelines: management of alcoholic liver disease European Association For The Study Of The Liver Journal of hepatology 57 (2), 399-420, 2012 | 767 | 2012 |
| Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver MR Teli, CP Day, OFW James, AD Burt, MK Bennett The Lancet 346 (8981), 987-990, 1995 | 694 | 1995 |
| Carriage of the PNPLA3 rs738409 C> G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma YL Liu, GL Patman, JBS Leathart, AC Piguet, AD Burt, JF Dufour, CP Day, ... Journal of hepatology 61 (1), 75-81, 2014 | 659 | 2014 |
| Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity S Shalapour, XJ Lin, IN Bastian, J Brain, AD Burt, AA Aksenov, ... Nature 551 (7680), 340-345, 2017 | 627 | 2017 |
| Elevated endotoxin levels in non-alcoholic fatty liver disease AL Harte, NF da Silva, SJ Creely, KC McGee, T Billyard, ... Journal of inflammation 7 (1), 15, 2010 | 614 | 2010 |
| Cancer-associated fibroblasts in gastrointestinal cancer H Kobayashi, A Enomoto, SL Woods, AD Burt, M Takahashi, DL Worthley Nature reviews Gastroenterology & hepatology 16 (5), 282-295, 2019 | 587 | 2019 |
| Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ QM Anstee, R Darlay, S Cockell, M Meroni, O Govaere, D Tiniakos, ... Journal of hepatology 73 (3), 505-515, 2020 | 544 | 2020 |
| Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major NF Olivieri, GM Brittenham, CE McLaren, DM Templeton, RG Cameron, ... New England Journal of Medicine 339 (7), 417-423, 1998 | 516 | 1998 |
| Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia International Consensus Group for Hepatocellular Neoplasia Hepatology 49 (2), 658-664, 2009 | 492 | 2009 |
| Diagnosis and interpretation of steatosis and steatohepatitis AD Burt, A Mutton, CP Day Seminars in diagnostic pathology 15 (4), 246-258, 1998 | 491 | 1998 |
| Liver fibrosis K Wallace, AD Burt, MC Wright Biochemical Journal 411 (1), 1-18, 2008 | 473 | 2008 |
